Here are four things to know.
1. The Guardian Connect system uses predictive analytics and artificial intelligence technology from IBM Watson Health to continually analyze glucose levels.
2. The system is the first smart continuous glucose monitoring system to alert patients of potential blood glucose events up to an hour ahead of time.
3. Guardian Connect can also pair to a smartphone, allowing users to track glucose levels in real-time and receive text alerts.
4. FDA approved the system for diabetes patients ages 14 to 75. Medtronic plans to launch Guardian Connect early this summer.
More articles on supply chain:
Canadian devicemaker to purchase Cogentix Medical for $239M
Cancer drug trial halted after patient death: 3 things to know
Case study: How Hartford HealthCare implemented 1 ERP system for all care sites
